Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
Uksha Saini,
Brentley Q. Smith,
Kalpana Deepa Priya Dorayappan,
Ji Young Yoo,
G. Larry Maxwell,
Balveen Kaur,
Ikuo Konishi,
David O’Malley,
David E. Cohn,
Karuppaiyah Selvendiran
Affiliations
Uksha Saini
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center
Brentley Q. Smith
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center
Kalpana Deepa Priya Dorayappan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center
Ji Young Yoo
Department of Neurosurgery, University of Texas, Health Science Center
G. Larry Maxwell
Inova Women’s Service Line and the Inova Schar Cancer Institute
Balveen Kaur
Department of Neurosurgery, University of Texas, Health Science Center
Ikuo Konishi
Division of GYN/ ONC, Kyoto University Graduate School of Medicine
David O’Malley
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center
David E. Cohn
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center
Karuppaiyah Selvendiran
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center
